HFA Premium Access

Heart Failure, diabetes & SGLT2 inhibition: time to change practice?

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure
Topic: Pharmacotherapy
Session type: Satellite Symposium
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim
Date: 25 May 2019
Time: 13:30 - 14:30

Session

5 presentations in this session

The essentials for diabetes and heart failure.

Speaker: Professor M. Cowie (London, GB)
Thumbnail

Why could patients with heart failure and T2DM benefit from SGLT2 inhibition?

Speaker: Professor S. Verma (Toronto, CA)
Thumbnail

Real world practices and outcomes in the management of heart failure patients with T2DM.

Speaker: Professor C. Lam (Singapore, SG)
Thumbnail

The future of SGLT2 inhibition in heart failure: managing patients without T2DM?

Speaker: Professor A. Voors (Groningen, NL)
Thumbnail

Panel discussion - Heart Failure, diabetes & SGLT2 inhibition: time to change practice?

Speaker: Professor M. Cowie (London, GB)
Thumbnail

5 speakers from this session

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

Professor Subodh Verma

St. Michael's Hospital, Toronto (Canada)
16 presentations
0 follower

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)
95 presentations
11 followers

Professor Adriaan Voors

University of Groningen, Groningen (Netherlands (The))
51 presentations
0 follower

Professor Martin Cowie

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
93 presentations
3 followers

This platform is supported by

logo Novo Nordisk